SLC5A2 and heart failure: Multiple studies investigating SGLT2-inhibitor prescribing practices have found variations in prescribing behaviour and rates depending on the indication.22, 26 Aligned with our findings, this underscores a clear need for improved patient education, particularly for the heart failure population.